{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:59:58Z","timestamp":1771603198611,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shire Human Genetic Therapies, Inc"},{"name":"Shire International GmbH"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bcmd.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T23:05:21Z","timestamp":1477004721000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey"],"prefix":"10.1016","volume":"68","author":[{"given":"Heather","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Belmatoug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Deegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Goker-Alpan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida Vanessa D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suma P","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoya","family":"Panahloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Zimran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2016.10.003_bb0005","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bcmd.2009.04.003","article-title":"The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause)","volume":"43","author":"Zimran","year":"2009","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0015","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0002-9378(95)91494-3","article-title":"Gynecologic and obstetric aspects of Gaucher's disease: a survey of 53 patients","volume":"172","author":"Granovsky-Grisaru","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ajh.24012","article-title":"Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: long-term data from phase III clinical trials","volume":"90","author":"Hughes","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-012-9528-4","article-title":"Long-term clinical outcomes in type 1 Gaucher disease following 10years of imiglucerase treatment","volume":"36","author":"Weinreb","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0030","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/jog.12254","article-title":"Outcome of pregnancies in women receiving velaglucerase alfa for Gaucher disease","volume":"40","author":"Elstein","year":"2014","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0035","author":"Actelion Pharmaceuticals US Inc."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0040","author":"Corporation"},{"key":"10.1016\/j.bcmd.2016.10.003_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejogrb.2010.12.024","article-title":"The management of pregnancy in Gaucher disease","volume":"156","author":"Granovsky-Grisaru","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0050","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s10545-008-0868-z","article-title":"Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry","volume":"31","author":"Fairley","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0055","doi-asserted-by":"crossref","first-page":"f3676","DOI":"10.1136\/bmj.f3676","article-title":"Diagnosis and management of first trimester miscarriage","volume":"346","author":"Jurkovic","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.bcmd.2016.10.003_bb0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ajog.2003.08.006","article-title":"Pregnancies in Gaucher disease: a 5-year study","volume":"190","author":"Elstein","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0065","author":"Christianson"},{"key":"10.1016\/j.bcmd.2016.10.003_bb0070","author":"European Medicines Agency"},{"key":"10.1016\/j.bcmd.2016.10.003_bb0075","author":"European Medicines Agency"},{"key":"10.1016\/j.bcmd.2016.10.003_bb0080","author":"Pfizer Laboratories Div Pfizer Inc."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0085","author":"Shire Human Genetic Therapies, Inc."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0090","author":"Corporation"},{"key":"10.1016\/j.bcmd.2016.10.003_bb0095","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ajh.24040","article-title":"Seven-year safety and efficacy with velaglucerase alfa for treatment-naive adult patients with type 1 Gaucher disease","volume":"90","author":"Zimran","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ajh.24007","article-title":"Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease","volume":"90","author":"Elstein","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcmd.2006.05.002","article-title":"National health budgets for expensive orphan drugs: Gaucher disease in Israel as a model","volume":"37","author":"Kesselman","year":"2006","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.10.003_bb0110","first-page":"852","article-title":"Alglucerase enzyme replacement therapy used safely and effectively throughout the whole pregnancy of a Gaucher disease patient","volume":"83","author":"Aporta Rodriguez","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2016.10.003_bb0115","author":"European Medicines Agency"},{"key":"10.1016\/j.bcmd.2016.10.003_bb0120","author":"European Medicines Agency"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961630225X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961630225X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:33:18Z","timestamp":1761049998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107997961630225X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":24,"alternative-id":["S107997961630225X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.10.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Shire Human Genetic Therapies, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}